CD8A and cancer: Similarly, the density of tumor-infiltrating lymphocytes (TILs), particularly tumor-associated antigen (TAA)-specific CD8+ T cells, has been linked to favorable clinical outcomes in numerous cancers [46,47], and is therefore considered a potential predictive biomarker [6,48].